First Time Loading...
O

Oncolys Biopharma Inc
TSE:4588

Watchlist Manager
Oncolys Biopharma Inc
TSE:4588
Watchlist
Price: 706 JPY -0.56% Market Closed
Updated: May 3, 2024

Oncolys Biopharma Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oncolys Biopharma Inc
Cash from Financing Activities Peer Comparison

Comparables:
2160
4587
4974
J
7774
S
4599

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
O
Oncolys Biopharma Inc
TSE:4588
Cash from Financing Activities
¥1.1B
CAGR 3-Years
68%
CAGR 5-Years
0%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Cash from Financing Activities
¥10.7B
CAGR 3-Years
137%
CAGR 5-Years
54%
CAGR 10-Years
11%
PeptiDream Inc
TSE:4587
Cash from Financing Activities
¥264.2m
CAGR 3-Years
N/A
CAGR 5-Years
19%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Cash from Financing Activities
-¥5.2B
CAGR 3-Years
-69%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
J
Japan Tissue Engineering Co Ltd
TSE:7774
Cash from Financing Activities
-¥535k
CAGR 3-Years
33%
CAGR 5-Years
39%
CAGR 10-Years
N/A
S
StemRIM Inc
TSE:4599
Cash from Financing Activities
¥202.6m
CAGR 3-Years
-70%
CAGR 5-Years
-30%
CAGR 10-Years
N/A

See Also

What is Oncolys Biopharma Inc's Cash from Financing Activities?
Cash from Financing Activities
1.1B JPY

Based on the financial report for Dec 31, 2023, Oncolys Biopharma Inc's Cash from Financing Activities amounts to 1.1B JPY.

What is Oncolys Biopharma Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
0%

The average annual Cash from Financing Activities growth rates for Oncolys Biopharma Inc have been 68% over the past three years .